Advent Technologies Holdings, Inc. (ADN)
Total Valuation
ADN has a market cap or net worth of $13.93 million. The enterprise value is $19.37 million.
| Market Cap | 13.93M |
| Enterprise Value | 19.37M |
Important Dates
The last earnings date was Tuesday, November 14, 2023, before market open.
| Earnings Date | Nov 14, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
ADN has 62.53 million shares outstanding. The number of shares has increased by 16.86% in one year.
| Shares Outstanding | 62.53M |
| Shares Change (YoY) | +16.86% |
| Shares Change (QoQ) | +13.02% |
| Owned by Insiders (%) | 25.10% |
| Owned by Institutions (%) | 13.58% |
| Float | 45.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.62 |
| Forward PS | n/a |
| PB Ratio | 0.43 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.34.
| Current Ratio | 1.84 |
| Quick Ratio | 0.51 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 519.87 |
Financial Efficiency
Return on equity (ROE) is -194.50% and return on invested capital (ROIC) is -217.07%.
| Return on Equity (ROE) | -194.50% |
| Return on Assets (ROA) | -128.80% |
| Return on Capital (ROIC) | -217.07% |
| Revenue Per Employee | $30,343 |
| Profits Per Employee | -$533,086 |
| Employee Count | 175 |
| Asset Turnover | 0.07 |
| Inventory Turnover | 0.67 |
Taxes
In the past 12 months, ADN has paid $413,000 in taxes.
| Income Tax | 413,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.55% in the last 52 weeks. The beta is 0.09, so ADN's price volatility has been lower than the market average.
| Beta (1Y) | 0.09 |
| 52-Week Price Change | -87.55% |
| 50-Day Moving Average | 0.38 |
| 200-Day Moving Average | 0.65 |
| Relative Strength Index (RSI) | 30.06 |
| Average Volume (30 Days) | 720,535 |
Short Selling Information
The latest short interest is 2.07 million, so 3.31% of the outstanding shares have been sold short.
| Short Interest | 2.07M |
| Short Previous Month | 1.91M |
| Short % of Shares Out | 3.31% |
| Short % of Float | 4.55% |
| Short Ratio (days to cover) | 3.01 |
Income Statement
In the last 12 months, ADN had revenue of $5.31 million and -$93.29 million in losses. Loss per share was -$1.76.
| Revenue | 5.31M |
| Gross Profit | -2.99M |
| Operating Income | -94.85M |
| Pretax Income | -92.88M |
| Net Income | -93.29M |
| EBITDA | -88.80M |
| EBIT | -93.06M |
| Loss Per Share | -$1.76 |
Balance Sheet
The company has $5.68 million in cash and $11.11 million in debt, giving a net cash position of -$5.44 million or -$0.09 per share.
| Cash & Cash Equivalents | 5.68M |
| Total Debt | 11.11M |
| Net Cash | -5.44M |
| Net Cash Per Share | -$0.09 |
| Equity / Book Value | 32.58M |
| Book Value Per Share | 0.52 |
| Working Capital | 10.70M |
Cash Flow
In the last 12 months, operating cash flow was -$26.30 million and capital expenditures -$15.02 million, giving a free cash flow of -$41.31 million.
| Operating Cash Flow | -26.30M |
| Capital Expenditures | -15.02M |
| Free Cash Flow | -41.31M |
| FCF Per Share | -$0.68 |
Margins
Gross margin is -56.31%, with operating and profit margins of -1,786.29% and -1,756.87%.
| Gross Margin | -56.31% |
| Operating Margin | -1,786.29% |
| Pretax Margin | -1,749.10% |
| Profit Margin | -1,756.87% |
| EBITDA Margin | -1,672.30% |
| EBIT Margin | -1,752.47% |
| FCF Margin | -778.02% |
Dividends & Yields
ADN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -669.61% |
| FCF Yield | -296.53% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.86% |
| Shareholder Yield | -16.86% |
Analyst Forecast
The average price target for ADN is $0.60, which is 169.30% higher than the current price. The consensus rating is "Hold".
| Price Target | $0.60 |
| Price Target Difference | 169.30% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ADN has an Altman Z-Score of -8.73 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.73 |
| Piotroski F-Score | 2 |